መነሻ › አልሰራቲቭ ኮላይቲስ › Texas › Houston
በHouston፣ TX ለአልሰራቲቭ ኮላይቲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአልሰራቲቭ ኮላይቲስ የሚደረጉ 17 ጥናቶች በHouston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · 7 ማይል ርቀት
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Baylor College of Medicine, Houston
- Intergrity Research, Houston
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
- Xencor Investigative Site, Houston
- Xencor Investigative Site, Houston
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Site US-030, Houston
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Victorium Clinical Research, Houston
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Texas Children's Hospital, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UT MD Anderson Cancer Center, Houston
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Integrity Advanced Therapeutics, Houston
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
ተሳታዮችን በመፈለግ ላይደረጃ 4
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- BAMC, Houston
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Baylor College of Medicine, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
ተሳታዮችን በመፈለግ ላይ
- Baylor College of Medicine, Houston
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Texas Children's Hospital - Baylor - PIN, Houston
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Mirador Therapeutics Selected Site, Houston
በሌሎች ከተሞች ለአልሰራቲቭ ኮላይቲስ የሚደረጉ ጥናቶች
- New York City, NY23 ጥናቶች
- Orlando, FL22 ጥናቶች
- Miami, FL21 ጥናቶች
- San Antonio, TX16 ጥናቶች
- Chicago, IL15 ጥናቶች
- Tacoma, WA15 ጥናቶች
- San Diego, CA15 ጥናቶች
- Tyler, TX14 ጥናቶች
- Colorado Springs, CO14 ጥናቶች
- Los Angeles, CA13 ጥናቶች
- St. Louis, MO13 ጥናቶች
- Washington, DC12 ጥናቶች
በHouston ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር145 ጥናቶች
- የጡንቻ ካንሰር126 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)121 ጥናቶች
- Metastatic Cancer104 ጥናቶች
- የኮሎሬክታል ካንሰር102 ጥናቶች
- የእንቁላል ካንሰር89 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ85 ጥናቶች
- የሳንባ ካንሰር78 ጥናቶች
- የፕሮስቴት ካንሰር76 ጥናቶች
- የኤንዶሜትሪየም ካንሰር68 ጥናቶች
- የፓንክሪያስ ካንሰር61 ጥናቶች
- ሜላኖማ59 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።